Although alpha-thalassemia is the most common genetic abnormality in t
he world, there is currently no routine laboratory method to definitiv
ely identify individuals who are affected. We describe a rapid and sim
ple method that utilizes deletion-sensitive primers to amplify normal
DNA sequences. Deletions involving the regions responsible for most of
the alpha-thalassemia cases in the US prevent amplification with thes
e primers. In tests with DNA isolated from small amounts (10 mu L) Of
whole blood, the deletion-sensitive primers gave rise to the expected
248-and 375-bp (base pair) amplification products in normal individual
s. These primers, along with primers designed to bind to a nonaffected
control sequence from the hemoglobin beta chain, could be amplified s
imultaneously (multiplex polymerase chain reaction). This made it poss
ible to detect heterozygotes for alpha-thalassemia-2 (one alpha locus
deleted) by determining the ratios of the 248- and 375-bp amplificatio
n products to the product of the control sequence (268 bp). The method
is rapid and simple and can be performed in a routine clinical labora
tory.